Biota Pharmaceuticals (United States)
- Research works
- 111 ▼ 28% vs 2013–17
- Citations
- 1.6k 14.0 per fractional work
- Top-10% rate
- 10.0% record average 16.5%
- Open access
- 52% world 28%
Not ranked overall: Biota Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.9×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 6.9×
- Immunology and Microbiology 5.4×
- Nursing 4.5×
- Biochemistry, Genetics and Molecular Biology 4.3×
- Medicine 2.1×
- Agricultural and Biological Sciences 1.9×
- Environmental Science 1.2×
- Dentistry 0.5×
- Neuroscience 0.4×
- Earth and Planetary Sciences 0.4×
- Chemistry 0.3×
- Computer Science 0.3×
- Engineering 0.3×
- Energy 0.2×
- Economics, Econometrics and Finance 0.1×
- Social Sciences 0.1×
- Materials Science 0.1×
Who are the top researchers at Biota Pharmaceuticals (United States)?
Ranked on the composite score, Mark Uhlik lead among researchers whose main affiliation is Biota Pharmaceuticals (United States).
- 1 Mark Uhlik United States · #778,964 worldwide 58 citations · 19 works
Which keywords describe research at Biota Pharmaceuticals (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Antioxidant, Oxidative Stress, Inflammation, Innovation, Circular Economy, Data Sharing and SARS-CoV-2.
- SARS-CoV-2
- Data Sharing
- Neurological Disorders
- Innovation
- Epidemiology
- Inflammation
- Cancer
- Oxidative Stress
- Antioxidant
- Immune Response
- Circular Economy
- Nutrition
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 12 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 12 words, with their numbers
- Cancer2▲ 5.7×8 topics
- Inflammation2▲ 3.6×12 topics
- Oxidative Stress2▲ 4.4×11 topics
- Epidemiology2▲ 1.79×12 topics
- Antioxidant2▲ 8.3×7 topics
- Innovation1▲ 4.2×2 topics
- Immune Response1▲ 6.2×5 topics
- Neurological Disorders1▲ 6.3×4 topics
- Circular Economy1▲ 12×2 topics
- Data Sharing1▲ 129×2 topics
- Nutrition1▲ 7.4×3 topics
- SARS-CoV-21▲ 10×3 topics
Which research topics does Biota Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Dermatology and Skin Diseases, Trace Elements in Health, Bioeconomy and Sustainability Development and Research Data Management Practices.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Dermatology and Skin Diseases Dermatology 1 works
- 2 Trace Elements in Health Nutrition and Dietetics 1 works
- 3 Bioeconomy and Sustainability Development General Agricultural and Biological Sciences 1 works
- 4 Research Data Management Practices Information Systems 1 works
- 5 Biotechnology and Related Fields Public Health, Environmental and Occupational Health 1 works
- 6 Genetically Modified Organisms Research Plant Science 1 works
- 7 Phytochemicals and Medicinal Plants Complementary and alternative medicine 1 works
- 8 COVID-19 Clinical Research Studies Infectious Diseases 0 works
- 9 Immune Cell Function and Interaction Immunology 0 works
- 10 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Biota Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 28% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Alpharetta
- Pediatrics and Genetics
- Engineering Associates (United States)
- Institute for Advanced Medical Research
- Chinese Medical Center
- Clearside Biomedical (United States)
- Alimera Sciences (United States)
- Veloxiti (United States)
- Rolta (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.